Therapeutic effect of DA-9601 on chronic reflux gastritis induced by sodium taurocholate in rats

doi:10.3748/wjg.v11.i47.7430

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4066)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

478

HTML

3154

Figures (1-9)

434

Sum=4066

Dec 21, 2005 (publication date) through May 30, 2025

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Dec 21, 2005; 11(47): 7430-7435
Published online Dec 21, 2005. doi: 10.3748/wjg.v11.i47.7430

Full Size Figure Download Figure

Figure 2 Inhibitory effects of DA-9601 and rebamipide on the length of mucosal lesion of TCA-induced erosive and atrophic gastritis in rats. DA-9601 (0.065% and 0.0.216%) and rebamipide (1.08%) were mixed with rodent chow and then administered to the rats. N: Normal; C: control; DL: 0.065% DA-9601; DH: 0.216% DA-9601; R: 1.08% rebamipide. Data are expressed as mean±SE. ^aP<0.05 vs controls.

Citation: Oh TY, Shin CY, Sohn YS, Kim DH, Ahn BO, Lee EB, Park CH. Therapeutic effect of DA-9601 on chronic reflux gastritis induced by sodium taurocholate in rats. World J Gastroenterol 2005; 11(47): 7430-7435
URL: https://www.wjgnet.com/1007-9327/full/v11/i47/7430.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i47.7430